Association of VEGF and VEGFR2 single nucleotide polymorphisms with hypertension and clinical outcome in metastatic clear cell renal cell carcinoma patients …
PURPOSE: Biomarkers that predict response or toxicity to antiangiogenic therapy are sought
to favorably inform the risk/benefit ratio. This study evaluated the association of vascular …
to favorably inform the risk/benefit ratio. This study evaluated the association of vascular …
Association of VEGF and VEGFR2 single nucleotide polymorphisms with hypertension and clinical outcome in metastatic clear cell renal cell carcinoma patients …
JJ Kim, SAJ Vaziri, BI Rini, P Elson… - Cancer …, 2012 - search.ebscohost.com
PURPOSE: Biomarkers that predict response or toxicity to antiangiogenic therapy are sought
to favorably inform the risk/benefit ratio. This study evaluated the association of vascular …
to favorably inform the risk/benefit ratio. This study evaluated the association of vascular …
Association of VEGF and VEGFR2 single nucleotide polymorphisms with hypertension and clinical outcome in metastatic clear cell renal cell carcinoma patients …
JJ Kim, SAJ Vaziri, BI Rini, P Elson, JA Garcia… - Cancer, 2012 - pubmed.ncbi.nlm.nih.gov
Purpose Biomarkers that predict response or toxicity to antiangiogenic therapy are sought to
favorably inform the risk/benefit ratio. This study evaluated the association of vascular …
favorably inform the risk/benefit ratio. This study evaluated the association of vascular …
Association of VEGF and VEGFR2 single nucleotide polymorphisms with hypertension and clinical outcome in metastatic clear cell renal cell carcinoma patients …
JJ Kim, SAJ Vaziri, BI Rini, P Elson, JA Garcia, R Wirka… - Cancer, 2012 - infona.pl
PURPOSE: Biomarkers that predict response or toxicity to antiangiogenic therapy are sought
to favorably inform the risk/benefit ratio. This study evaluated the association of vascular …
to favorably inform the risk/benefit ratio. This study evaluated the association of vascular …
Association of VEGF and VEGFR2 single nucleotide polymorphisms with hypertension and clinical outcome in metastatic clear cell renal cell carcinoma patients …
JJ Kim, SA Vaziri, BI Rini, P Elson, JA Garcia, R Wirka… - Cancer, 2011 - europepmc.org
Purpose Biomarkers that predict response or toxicity to antiangiogenic therapy are sought to
favorably inform the risk/benefit ratio. This study evaluated the association of vascular …
favorably inform the risk/benefit ratio. This study evaluated the association of vascular …
Association of VEGF and VEGFR2 single nucleotide polymorphisms with hypertension and clinical outcome in metastatic clear cell renal cell carcinoma patients …
JJ Kim, SAJ Vaziri, BI Rini, P Elson, JA Garcia… - Cancer, 2012 - pure.johnshopkins.edu
PURPOSE: Biomarkers that predict response or toxicity to antiangiogenic therapy are sought
to favorably inform the risk/benefit ratio. This study evaluated the association of vascular …
to favorably inform the risk/benefit ratio. This study evaluated the association of vascular …
[引用][C] Association of VEGF and VEGFR2 single nucleotide polymorphisms with hypertension and clinical outcome in metastatic clear cell renal cell carcinoma patients …
JJ Kim, SAJ Vaziri, BI Rini, P Elson, JA Garcia, R Wirka… - Cancer, 2011 - cir.nii.ac.jp
Association of VEGF and VEGFR2 single nucleotide polymorphisms with hypertension and
clinical outcome in metastatic clear cell renal cell carcinoma patients treated with sunitinib …
clinical outcome in metastatic clear cell renal cell carcinoma patients treated with sunitinib …
[HTML][HTML] Association of VEGF and VEGFR2 Single Nucleotide Polymorphisms with Hypertension and Clinical Outcome in Metastatic Clear Cell Renal Cell Carcinoma …
JJ Kim, SAJ Vaziri, BI Rini, P Elson, JA Garcia, R Wirka… - Cancer, 2012 - ncbi.nlm.nih.gov
PURPOSE Biomarkers that predict response or toxicity to antiangiogenic therapy are sought
to favorably inform the risk/benefit ratio. This study evaluated the association of vascular …
to favorably inform the risk/benefit ratio. This study evaluated the association of vascular …
[引用][C] Association of VEGF and VEGFR2 Single Nucleotide Polymorphisms with Hypertension and Clinical Outcome in Metastatic Clear Cell Renal Cell Carcinoma …
JJ KIM, SAJ VAZIRI, BI RINI, P ELSON, JA GARCIA… - Cancer, 2012 - pascal-francis.inist.fr
Association of VEGF and VEGFR2 Single Nucleotide Polymorphisms with Hypertension
and Clinical Outcome in Metastatic Clear Cell Renal Cell Carcinoma Patients Treated With …
and Clinical Outcome in Metastatic Clear Cell Renal Cell Carcinoma Patients Treated With …